Health News Briefs: Anesthesia Concerns, Ebola Innovations, and Global Health Challenges

The latest health news covers FDA's investigation into anesthesia-related neurological issues, Congo's Ebola treatment trial, and the U.S. lowering its mortality rate by 4.6%. The rapid Ebola test sees potential manufacturers, while malaria and hunger crises escalate. The U.S promises $1.3 billion for Tanzania's health, and Brazil contends with EU export rules.

The FDA is probing the safety of sevoflurane, a common anesthetic, due to neurological issues in patients of Venezuelan ancestry, possibly linked to a genetic variant. Investigations cover both adult and pediatric cases after multiple scientific reports highlighted the problem.

In the Democratic Republic of Congo, a milestone has been reached with the first patient enrolled in a treatment trial for the Bundibugyo Ebola virus. This comes amid security challenges, including a recent attack claiming lives at an Ebola treatment facility.

Health developments continue globally. The U.S. mortality rate dropped by 4.6% in 2025, though flu-related deaths increased. In Congo, other diseases such as malaria become as alarming as Ebola. Meanwhile, the U.S. signs a significant health investment deal with Tanzania, and Brazil adapts to meet EU antimicrobial rules to avoid logistic disruptions.